跳至主要内容
临床试验/NCT05579704
NCT05579704已完成不适用

Digital Intervention for Behaviour Change and Chronic Disease Prevention

University of Alberta1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2022年11月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
186
试验地点
1
主要终点
Change in body weight.

研究概览

简要总结

Body weight, diet quality, physical activity, stress, sleep and alcohol use will be evaluated in a sample of 180 Albertans with excess body weight. Participants will be randomized into the following two groups; active control arm (access to a preventative self-care web-based platform for 16 weeks) vs. intervention arm (access to a preventative self-care web-based platform for 16 weeks plus health professional guidance and supervision).

详细描述

Excess body weight, poor diet, physical inactivity, alcohol consumption, stress, and sleep deprivation/disruption are modifiable risk factors associated with chronic diseases, such as cancer. While most Canadians may be aware that these play a role in chronic disease prevention, individualized tools are needed to foster sustainable, long-term habits.

Digital health solutions have become commonplace in self-care. They offer an opportunity to reach a large number of individuals with personalized programs to improve health and lower the risk of developing chronic disease. Many digital applications are available for individuals to monitor their diet, activity and weight; however, few have been validated and are based on scientific evidence.

Recently, a Canadian web-based platform centered on preventive self-care became available. This platform was created by health care professionals and encompasses three key pillars of health: nutrition, physical activity, and mindfulness. The effectiveness of this web-based wellness platform will be evaluated in people living with excess body weight to improve six chronic disease risk factors: body weight, diet quality, physical activity, alcohol intake, stress, and sleep habits. A fully self-guided approach (active control, Arm 1) will be compared to an approach guided by a healthcare professional (Arm 2) and compare risk factors pre- and post-intervention. Investigators hypothesize that both approaches will improve modifiable risk factors, but participants guided by a healthcare professional will have greater improvements. Qualitatively, the experiences of immigrants using the platform will be explored.

Participants will use the web-based platform for 16 weeks. Our primary outcome is between-group difference in weight loss. Secondary outcomes include improvements in dietary intake, physical activity and sleep quality, and decrease in alcohol intake and stress. To assess the primary and one of the secondary outcomes (physical activity), a smart scale and a wearable device will be used. Wearable devices are widely used and an effective approach to body weight reduction. Additionally, immigrants' experiences and perspectives of participating in this study will be explored using semi-structured interviews.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Albertans with excess body weight (BMI 30-35 kg/m2)
  • Individuals who are seeking weight loss as screened by the S-Weight Questionnaire
  • Ages 40-65 years of age, any sex/gender
  • Able to safely exercise as screened by the 2022 Physical Activity Readiness Questionnaire (PAR-Q+)
  • Must have a cell phone with internet access and Bluetooth capabilities
  • Able to participate in video conferencing on evenings and/or weekends
  • Willing to wear a Fitbit activity monitor on the wrist for 16 weeks.
  • Able to speak, read and understand English

排除标准

  • Participating in intensive lifestyle interventions, structured exercise programming (> 3hrs of vigorous physical activity per week) or structured diet programming
  • Taking any medication or supplements that may alter energy metabolism, body weight and composition, as evaluated by study investigators;
  • Chronic conditions in which weight loss is not indicated or controversial. Significant medical self-reported comorbidities, including uncontrolled metabolic disorders (e.g., cancer, thyroid, stroke, kidney, liver, respiratory, heart disease, type 1 or uncontrolled type 2 diabetes)
  • Self-reported eating disorders, untreated depression, anxiety or other mood disorders
  • Weight loss greater than 25 lbs (11 kg) in the past 6 months
  • Previous bariatric surgery
  • Active substance abuse (alcohol, cannabis, illicit drugs, prescription drugs)
  • Unable to adhere to the study protocol

结局指标

主要结局

Change in body weight.

时间窗: Baseline to Week 16.

Body weight changes will be measured using Bluetooth enabled smart scales (Fitbit Aria scale) for daily tracking of body weight.

次要结局

  • Change in physical activity.(Baseline to Week 16.)
  • Change in diet quality.(Baseline to Week 16.)
  • Change in measured step counts.(Baseline to Week 16.)
  • Change in self-reported sleep quality.(Baseline to Week 16.)
  • Change in self-reported stress.(Baseline to Week 16.)
  • Change in self-reported alcohol use.(Baseline to Week 16.)
  • Change in self-reported physical activity.(Baseline to Week 16.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验